official impact factor

4.36

Advanced search

Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study

Patrick H Dessein^*, Barry I Joffe and Anne E Stanwix

* Corresponding author: Patrick H Dessein Dessein@lancet.co.za

Arthritis Res 2002, 4:R12 doi:10.1186/ar597

Accesses

Last 30 days: 59 accesses
Last year: 510 accesses
All time: 6850 accesses

Cited by

BioMed Central: 3 citations

Cardiovascular co-morbidity in patients with rheumatic diseases

Johan Frostegård Arthritis Research & Therapy 2011, 13:225 (30 June 2011)

This article is part of a collection on Comorbid conditions in...

Abstract | Full text | PDF | PubMed

Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study

Tracey E Toms, Vasileios F Panoulas, Holly John, Karen MJ Douglas, George D Kitas Arthritis Research & Therapy 2009, 11:R110 (16 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis

Patrick H Dessein, Angela J Woodiwiss, Barry I Joffe, Gavin R Norton BMC Cardiovascular Disorders 2007, 7:31 (29 October 2007)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations